Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

MoU with Vattenfall

Aker Carbon Capture has signed a Memorandum of Understanding with Sweden’s Vattenfall to accelerate the evaluation of future carbon capture plants in Sweden and Northern Europe.The agreement will support Vattenfall´s ambitions to achieve negative emissions in waste and bio CCS plants and make it possible to live fossil free within one generation, the company says. “We look forward to cooperating with Aker Carbon Capture and together develop solutions for large-scale commercial bio-CCS plants in Sweden and Northern Europe. With Vattenfall´s extensive track record within sustainability

Haldex Interim Report, July - September 2020

Gradual recovery and positive operating incomeTHIRD QUARTER 2020             · Sales declined organically by 19% and totaled SEK 964m (1,283). The downturn is mainly explained by COVID-19 and its impact on new manufacturing of trucks and trailers. The aftermarket was more stable. · Adjusted operating income totaled SEK 58m (85), equivalent to an adjusted operating margin of 6.0% (6.6). Fixed costs decreased by a total of SEK 49m in the quarter. The structural savings programs of SEK 200 million in annual savings contributed SEK 26 million in the quarter. Full effect is expected to

Alligator Bioscience focuses on ATOR-1017 and mitazalimab

Lund, Sweden, October 22, 2020 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced the decision to focus its resources on the two proprietary candidate drugs, ATOR-1017 and mitazalimab. Positive safety and strong Proof of Mechanism data support moving both into clinical efficacy (Phase Ib/II) studies in 2021. Due to this prioritization, Alligator will complete the ongoing dose-escalation study with the bispecific ATOR-1015 as planned during Q4 2020, after which it will be partnered for further development. “ATOR-1017 and mitazalimab are frontrunners worldwide and Alligator

Invitation: Presentation of Ambea’s third quarter 2020 results

Hosts: Fredrik Gren, CEO and Benno Eliasson, CFO.On November 5th at 07:00 (CET) Ambea will publish its’ third quarter 2020 results. In connection to the announcement, Ambea will host a telephone conference at 10:00 (CET) on Thursday, November 5th. The presentation will be held in English and also available as webcast on www.ambea.com or direct link: https://edge.media-server.com/mmc/p/dz59u2r5 To ensure that you are connected to the conference call, please dial in at least ten minutes before the start of the conference call to register your attendance. Code for registration:

Assemblin to carry out comprehensive multidisciplinary project for AstraZeneca

Assemblin has won the assignment to carry out multidisciplinary technical installations in the area of electricity, ventilation, cooling, sanitation, control and ironwork for AstraZeneca in Södertälje, Sweden. The sum total of the contracts is approximately SEK 46 million.The assignment pertains to ensuring cooling and dehumidification capacity for climate control and process cooling at the facility in Södertälje. The project involves the installation of new cooling towers, refrigerant coolers, and liquid cooling units that produce a higher cooling effect and lower power consumption. The

Alma Media’s Interim Report January–September 2020: In Q3, profitability at the level of the comparison period despite the decline in revenue

Alma Media Corporation               Interim Report                   22 October 2020 at 8:00 a.m. (EEST) ALMA MEDIA’S INTERIM REPORT JANUARY–SEPTEMBER 2020: In Q3, profitability at the level of the comparison period despite the decline in revenue Financial performance July–September 2020: · Revenue from continuing operations MEUR 54.0 (58.2), down 7.4%. · Adjusted operating profit from continuing operations MEUR 13.2 (13.5), down 2.3%. · Operating profit from continuing operations MEUR 13.2 (13.6), down 3.2%. · Earnings per share from continuing operations EUR 0.12 (0.

ArcticZymes Technologies Q3 2020 Results

Tromsø, Norway, 22 October 2020 – ArcticZymes Technologies (OSE: AZT) reported sales of NOK 30.8 million (22.5) and an EBITDA of NOK 10.1 million (0.8) for the third quarter of 2020. Underlying growth continues.Highlights from Q3 2020 · Annual group sales exceed 100 MNOK for the first time · Gross profit for the Group improved 65% to NOK 26.0 million (Q3 2019: NOK 15.7 million) · ArcticZymes had Q3 sales of NOK 19.5 million growing by 63% (Q3 2019: NOK 12.0 million) · Biotec BetaGlucans had Q3 sales of NOK 11.2 million growing by 7% (Q3 2019: NOK 10.5 million) · Upsides

Archer announces two-year contract extension for platform drilling and maintenance services in the UK North Sea

Hamilton, Bermuda (October 22, 2020)   Archer has secured a two-year contract extension with a major North Sea operator for the provision of platform drilling operations and maintenance services on seven UK North Sea installations. The extension will commence November 1, 2020 in direct continuation of the current contract. Over the next two years Archer will continue to deliver drilling operations, maintenance and intervention support services including the provision of well services and rental equipment. In addition, Archer’s engineering team has been contracted to conduct one rig

Atria had a strong third quarter: the company's net sales and EBIT increased, and profitability was at a good level

Atria Plc, Interim report, 22 October 2020, 8.00 amInterim report of Atria Plc, 1 January–30 September 2020Atria had a strong third quarter: the company's net sales and EBIT increased, and profitability was at a good levelJuly–September 2020- Consolidated net sales totalled EUR 382.4 million (EUR 366.0 million).- Consolidated EBIT was EUR 19.0 million (EUR 16.7 million), or 5.0 per cent (4.6%) of net sales.- All business areas posted a positive EBIT.- Atria Finland's net sales increased, and EBIT was on par with the previous year. Net sales and EBIT were boosted by pork

Year-end report 1 September 2019 - 31 August 2020

Corporate restructuring ends The coronavirus crisis continued to affect RNB in the fourth quarter, although to a lesser extent than in the third quarter. The corporate restructuring has proceeded according to plan, including operational changes, and the companies are now in good shape as the process comes to an end at the beginning of November. Operating income and cash flow for the quarter improved in year-on-year terms.FOURTH QUARTER, JUNE 1, 2020 – AUGUST 31, 2020 IN SUMMARY · Net sales decreased to SEK 326 M (552). · Comparable sales for the Group on all national markets

TOMRA: Key information relating to the proposed cash dividend to be paid by Tomra Systems ASA

Dividend amount: NOK 2.75 per share Declared currency: NOK Last day including right: 23 October 2020 Ex-date: 26 October 2020 Record date: 27 October 2020 Payment date: 5 November 2020 Date of approval: 21 October 2020 Entitled to dividend are the shareholders owning the shares at the end of 23 October 2020. The ex-dividend date is 26 October 2020, and the record date is 27 October 2020. The dividend will be distributed on 5 November 2020. *** This information is published in accordance with the requirements of the Continuing Obligations. This information is

Increased market shares and strong earnings

Axfood sums up a strong quarter with growth that once again exceeded the market and improved profitability. An impressive performance for the Willys stores and a recovery for Snabbgross more than compensated for the businesses that continue to be challenged by the ongoing pandemic.President and CEO Klas Balkow’s comments on the interim report for the third quarter 2020: “Axfood continues to gain market shares, and particularly noteworthy was growth for Willys, which is strengthening its position as Sweden’s leading discount grocery chain. Profit for the third quarter was strong, and

Essity raises target for adjusted return on capital employed to above 17% by 2025

Essity is raising its target for adjusted return on capital employed to above 17% by 2025. The previous target of above 15% for adjusted return on capital employed has been achieved during the last 12 months. The raised target will be achieved through the continued execution of Essity’s existing strategy, an accelerated digital transformation and further streamlining of production, logistics and distribution. Other financial targets remain unchanged.Essity’s innovation-driven category and channel strategy with leading brands combined with comprehensive efficiency improvements have

TOMRA: 3Q 2020 - Solid development in third quarter

Third quarter 2020 marked a return to normal despite the headwind brought about by the COVID-19 pandemic. The essential nature of the markets that TOMRA serves is a strength, while technology continues to be a success factor for our customers. Revenues in the third quarter 2020 amounted to 2,578 MNOK compared to 2,378 MNOK in third quarter last year. Currency adjusted revenues were up 3% for TOMRA Group. Revenues were down 1% in TOMRA Collection Solutions and up 7% in TOMRA Sorting Solutions, currency adjusted. Gross margin was 46% in the quarter, up from 45% in third quarter 2019,

Interim report January–September 2020

Resilient performance with strong cash generation Key highlights · Stable sales volumes despite challenging markets · Successfully accomplished maintenance shutdowns · Accelerated delivery of the cost and efficiency programme · Strong operating cash flow generation · Recyclable Flow Wrap launched Quarterly data · Net sales declined by 5% to SEK 5 561 million (5 833). Excluding currency effects sales declined by 3% · Adjusted EBITDA* was SEK 570 million (639), negatively affected by timing of annual maintenance shutdowns · Operating profit was SEK 86 million

First day of trading in Nordic Paper’s shares on Nasdaq Stockholm

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE.For complete press release, please refer to the link: https://www.nordic-paper.com/investors/ipo-confirm For further information, please contact: Anita Sjölander, CEO of Nordic Paper Holding AB (publ)Tel: +46

Interim Report Third Quarter 2020

JANUARY 1 – SEPTEMBER 30, 2020(compared with the corresponding period a year ago) · Target raised for adjusted return on capital employed to above 17% by 2025. The previous target of above 15% for adjusted return on capital employed has been achieved during the last 12 months. · Net sales declined 4.7% to SEK 90,796m (95,289) · Organic net sales declined 2.4% · Sales were negatively impacted by the COVID-19 pandemic and related lockdowns · In emerging markets, which accounted for 36% of net sales, organic net sales increased 1.2% · Operating profit before amortization

Continued positive earnings trend and strong cash flows in the third quarter

“EBITA in the business group increased by 28% in the third quarter of 2020. For the last 12-month period, EBITA amounted to SEK 1,669m, up 60%. Cash flow also remained strong and contributed to the continuing decline in leverage. As earnings levels also improve, Ratos’s leverage has fallen to 1.4x* in the third quarter of 2020, compared with 3.0x in the third quarter of 2019. After the end of the period, an agreement was signed to divest Bisnode to Dun & Bradstreet. The divestment is a good deal for Ratos and reduces risk in the business group while freeing up capital. This enables us to

SEB's third quarter 2020 result

Press releaseStockholm, 22 October 2020 The operating profit for the third quarter 2020 amounted to SEK 5.9bn with a return on equity of 11.7 per cent and a Common Equity Tier 1 capital ratio of 19.4 per cent. The Board of Directors confirms its previous decision to not propose a dividend during 2020. "Despite the challenging economic environment, SEB delivered a robust financial performance. Higher net interest income, lower expenses and lower credit losses were offset by valuation effects that came down from the elevated level in the second quarter. We continue to see limited

Atria renews its strategy and updates its financial targets: Atria is a Winning Northern European Food Company

Atria Plc, Company Announcement October 22, 2020 at 7.50 amAtria renews its strategy and updates its financial targets: Atria is a Winning Northern European Food CompanyAtria Plc's Board of Directors has approved the company's renewed strategy for 2021-2025 and updated financial targets, which will take effect on 1 January 2021.“Atria's net sales have grown steadily since 2015 and our profitability has remained at a good level. Our previous Healthy Growth strategy has proven its worth and our goals have steered us in the right direction. In order to meet the changing challenges of our

NeoDynamics carries out directed new share issue of approximately SEK 90 million and convenes extraordinary general meeting

The board of directors of NeoDynamics AB (“NeoDynamics” or the “Company”) proposes that an extraordinary general meeting is convened to resolve on a directed new share issue to a limited group of investors (the “Share Issue”). The subscription price is proposed to be SEK 3.71 per share and is decided through an accelerated bookbuilding process. The Share Issue can bring approximately SEK 90 million before transaction costs to the Company. As a result of the Share Issue, Cardeon Futuring Finance (“Cardeon”) - with Chairman of the Board Masoud Khayyami together with the the management team -

Etrion Announces Potential Sale of Japanese Solar Assets

October 21, 2020, Geneva, Switzerland – Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX / OMX: ETX), a solar independent power producer, announces that it is exploring strategic alternatives to maximize the value of its solar portfolio in Japan.  Etrion has engaged Mitsubishi UFJ Morgan Stanley Securities Co., Ltd (“MUMSS”) as financial advisor to assist with the potential sale of the Company’s 57-megawatt operating solar portfolio and its 45-megawatt solar park under construction in Japan. The Company has received several non-binding proposals from strategic and financial

Acquisition of own shares / primary insider trades

On behalf of Gjensidige (OSE:GJF), DNB has on 21 October 2020 acquired 64 177 shares. The shares have been acquired at an average price of NOK 196,0086 per share. 51 741 shares have been sold to employees, at a price of NOK 196,0086 per share, as part of the Gjensidige share savings scheme 2020. Acquisition of shares for the share savings scheme for the third quarter 2020 is now completed. A total of 11 885 bonus shares are allocated to employees pursuant to the terms of previous years’ share savings scheme. Bonus shares are allocated without further consideration. Gjensidige

There are no items matching the current filter
There are no more items matching the current filter
Back to top